He completed his post-medical residency in Internal Medicine and fellowships in Hematology and Oncology at Cook County Hospital in Chicago, Illinois
The single-payer public system, generic semaglutide approval, patent lapse due to missed maintenance fee, the presence of provincial supply protection laws, reimbursement models for obesity indication, and comprehensive societal value modeling are certain factors that are driving the semaglutide market in Canada
The drug mimics GLP-1, a hormone the body produces after eating, which can decrease appetite and help the body manage insulin production
Dose-Response Patterns The FDA-approved dose is 1.75 mg subcutaneous as needed, 45 minutes before anticipated sexual activity, with a maximum of 8 doses per month
The most commonly reported side effects of GLP-1 drugsnausea, vomiting, and gastrointestinal upsetare generally mild and tend to decrease as your body adjusts over the first few weeks of treatment